Drug Trial Radar · NCT01448213
Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK)
Last checked: Nov 19, 2026Latest source record: Sep 3, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
264
Actual
Start
Oct 2011
Primary completion
Jan 2014
Study completion Jan 2014
Sponsor
- Lead sponsor
- Price Vision GroupIndustry
- Sponsor type
- Industry
- First posted
- Oct 7, 2011
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (investigator)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare two different commonly used steroid dosing regimens after Descemet's membrane endothelial keratoplasty (DMEK) transplant surgery. The investigators hope to determine if one is more effective at preventing rejection or if both are equally effective.
Conditions
- Fuchs' Dystrophy
- Bullous Keratopathy
Interventions
Prednisolone acetateDrug
Subjects assigned to Treatment Regimen A will instill 1 drop of prednisolone acetate 1% four times a day in the transplant eye for 3 months, then 3 times a day for one month, then twice a day for one month, then once a day until the subject exits the study.
FluorometholoneDrug
Subjects assigned to Treatment Regimen B will instill 1 drop of prednisolone acetate 1% four times a day in the transplant eye for one month. Then they will instill one drop of fluorometholone four times a day in the transplant eye for 2 months, then 3 times a day for 1 month, then twice a day for 1 month, then once a day until the subject exits the study.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Eyes With Immunologic Graft Rejection EpisodesTime frame: Within 1 year
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
Price Vision Group
Indianapolis, Indiana
University of Erlangen
Erlangen, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.